A New Ticker

Aug 02, 2010

The Mountain View, Calif.-based sequencing-as-a-service company Complete Genomics "plans to sell up to an estimated $86.3 million in an initial public offering," according to the Wall Street Journal, and is "staking its claim to the ticker symbol GNOM" on the Nasdaq, the San Jose Mercury News reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

More Details Wanted

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

And a Third

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Glimpses of Viral Origins

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.

Menu

A New Ticker

To read the full story....

Breaking News

OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

NanoString Technologies Q4 Revenues Fall 2 Percent

Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

Seqster, Medable Team on Data Integration for Clinical Trials

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

The Scan

More Details Wanted

And a Third

Glimpses of Viral Origins

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

Sponsorships